Literature DB >> 16034581

[Clinical pharmacology of analgesics: outlook and risks].

E Beubler1.   

Abstract

Despite that many drugs are available for pain treatment, many patients are still suffering because of wrong choice or wrong use of analgesics. Both are determined by the degree and the nature of pain to be treated. Non-opioid drugs, especially COX-2-inhibitors are extensively evaluated. If treatment with these drugs is not sufficient, opioids have to be used. Their efficiency is outstanding and their side effects are appropriate. However, doctors and nurses are still reluctant to use opioids because of overestimation of respiratory depression and addiction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16034581     DOI: 10.1007/s00108-005-1465-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  12 in total

1.  Comparison of inhibitory effects of meloxicam and diclofenac on human thromboxane biosynthesis after single doses and at steady state.

Authors:  I Tegeder; J Lötsch; S Krebs; U Muth-Selbach; K Brune; G Geisslinger
Journal:  Clin Pharmacol Ther       Date:  1999-05       Impact factor: 6.875

2.  Effect of ibuprofen on cardioprotective effect of aspirin.

Authors:  T M MacDonald; L Wei
Journal:  Lancet       Date:  2003-02-15       Impact factor: 79.321

3.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Authors:  Robert S Bresalier; Robert S Sandler; Hui Quan; James A Bolognese; Bettina Oxenius; Kevin Horgan; Christopher Lines; Robert Riddell; Dion Morton; Angel Lanas; Marvin A Konstam; John A Baron
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

4.  Opioid pseudoaddiction--an iatrogenic syndrome.

Authors:  D E Weissman; J D Haddox
Journal:  Pain       Date:  1989-03       Impact factor: 6.961

5.  A multicenter, randomized, double blind study comparing lornoxicam with diclofenac in osteoarthritis.

Authors:  B Kidd; W Frenzel
Journal:  J Rheumatol       Date:  1996-09       Impact factor: 4.666

6.  A randomized trial of aspirin to prevent colorectal adenomas.

Authors:  John A Baron; Bernard F Cole; Robert S Sandler; Robert W Haile; Dennis Ahnen; Robert Bresalier; Gail McKeown-Eyssen; Robert W Summers; Richard Rothstein; Carol A Burke; Dale C Snover; Timothy R Church; John I Allen; Michael Beach; Gerald J Beck; John H Bond; Tim Byers; E Robert Greenberg; Jack S Mandel; Norman Marcon; Leila A Mott; Loretta Pearson; Fred Saibil; Rosalind U van Stolk
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

7.  Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

Authors:  L A García Rodríguez; H Jick
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

8.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors:  F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal:  JAMA       Date:  2000-09-13       Impact factor: 56.272

Review 9.  Anti-inflammatory effects of aspirin and sodium salicylate.

Authors:  Rainer Amann; Bernhard A Peskar
Journal:  Eur J Pharmacol       Date:  2002-06-28       Impact factor: 4.432

10.  Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs.

Authors:  M J Langman; J Weil; P Wainwright; D H Lawson; M D Rawlins; R F Logan; M Murphy; M P Vessey; D G Colin-Jones
Journal:  Lancet       Date:  1994-04-30       Impact factor: 79.321

View more
  1 in total

Review 1.  NSAID hypersensitivity - recommendations for diagnostic work up and patient management.

Authors:  Stefan Wöhrl
Journal:  Allergo J Int       Date:  2018-05-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.